References of "Vrints, C"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailThe role of multi-imaging modality in primary mitral regurgitation
Van de Heyning, C.; Magne, Julien ULg; Vrints, C. et al

in European Journal of Echocardiography (2012), 13(2), 139-151

Primary mitral regurgitation (MR) is the first cause of valvular regurgitation in Western countries. Echocardiography is the cornerstone for diagnosing MR and more specifically for establishing its ... [more ▼]

Primary mitral regurgitation (MR) is the first cause of valvular regurgitation in Western countries. Echocardiography is the cornerstone for diagnosing MR and more specifically for establishing its aetiology and mechanism, for quantifying its severity, progression, and repercussion and for assessing the likelihood of successful of valve repair. Two-dimensional/three-dimensional transthoracic and transoesophageal echocardiography <br />are the most widely used methods. Interest is growing for exercise echocardiography particularly in patients in whom symptoms do not correlate well with MR severity and for risk stratification. The experience of multi-slice computed tomography in primary MR is still limited. Conversely, cardiovascular magnetic resonance has gained progressive relevance and represents the alternative method of choice. [less ▲]

Detailed reference viewed: 31 (9 ULg)
Full Text
Peer Reviewed
See detailMise en pratique du traitement de reperfusion dans les infarctus du myocarde avec elevation du segment ST.
Claeys, M. J.; Gevaert, S.; de Meester, A. et al

in Revue medicale de Liege (2010), 65(1), 23-8

Myocardial infarction remains a major healthcare problem. Reperfusion therapy has been shown to influence favourably short- and long-term patient survival. The authors reviewed the data of early ... [more ▼]

Myocardial infarction remains a major healthcare problem. Reperfusion therapy has been shown to influence favourably short- and long-term patient survival. The authors reviewed the data of early recognition of STEMI (ST Elevation Myocardial Infarction), the reperfusion modalities including a flowchart management, as proposed by the Belgian working groups (BIWAC and BWGIC), and the lessons learned from European and American registries. Primary PCI often remains the treatment of choice. A national policy is still required to implement the guidelines and improve clinical practice for our STEMI patients. [less ▲]

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailMise en pratique du traitement de reperfusion dans les infarctus du myocarde avec elevation du segment ST (STEMI). Recommandations actualisees de la Societe Belge de Cardiologie et de ses groupes de travail: le Groupe Interdisciplinaire de Cardiologie Aigue (BIWAC) et le Groupe de Cardiologie Interventionnelle (BWGIC).
Claeys, M. J.; Gevaert, S.; de Meester, A. et al

in Revue medicale de Bruxelles (2010), 31(1), 30-4

Myocardial infarction remains a major healthcare problem. Reperfusion therapy has been shown to influence favourably short- and long-term patient survival. The authors reviewed the data of early ... [more ▼]

Myocardial infarction remains a major healthcare problem. Reperfusion therapy has been shown to influence favourably short- and long-term patient survival. The authors reviewed the data of early recognition of STEMI (ST Elevation Myocardial Infarction), the reperfusion modalities including a flowchart management, as proposed by the Belgian working groups (BIWAC and BWGIC), and the lessons learned from European and American registries. Primary PCI often remains the treatment of choice. A national policy is still required to implement the guidelines and improve clinical practice for our STEMI patients. [less ▲]

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailStudy of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): A first-in-human multicenter pilot trial
Liu, X. S.; Huang, Y. M.; Hanet, C. et al

in Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions (2003), 60(2), 172-178

The aim of this multicenter pilot study was to evaluate the acute safety and efficacy of the dexamethasone-eluting stent (0.5 mug/mm(2) of stent) implanted in patients with de novo single-vessel disease ... [more ▼]

The aim of this multicenter pilot study was to evaluate the acute safety and efficacy of the dexamethasone-eluting stent (0.5 mug/mm(2) of stent) implanted in patients with de novo single-vessel disease. This study included 71 patients, 42% of whom had unstable angina pectoris. An appropriately sized BiodivYsio Matrix Lo stent loaded with a total dexamethasone dose of 0.5 mug/mm(2) of stent was used. Technical device success rate was 95%. Six-month MACE occurred in two patients (3.3%). Binary restenosis rate was 13.3%. Late loss was 0.45. Late loss and percent diameter stenosis were lower in the unstable angina pectoris patients compared to the stable patients (0.32 +/- 0.39 vs. 0.60 +/- 0.55 mm, P < 0.07, and 26.86 +/- 14 vs. 38.40 +/- 16%, P < 0.02). This study demonstrated the feasibility and safety of the implantation of a dexamethasone-eluting stent and its effect on in-stent neointimal hyperplasia. (C) 2003 Wiley-Liss, Inc. [less ▲]

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailGuidelines for percutaneous coronary intervention by the Belgian Working Group on Invasive Cardiology
Legrand, Victor ULg; Wijns, W.; Vandenbranden, F. et al

in Acta Cardiologica (2003), 58(4), 341-348

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailLong-term follow-up from the STRIDE (anti-restenosis with the biodivysio dexamethasone-eluting stent) clinical study
Liu, X.; Hanet, C.; Legrand, Victor ULg et al

in European Heart Journal (2003), 24(Suppl. S), 268

Detailed reference viewed: 8 (1 ULg)
Peer Reviewed
See detailBWGIC guidelines for training and quality control in adult interventional cardiology. Belgian Working Group of Invasive Cardiology.
Legrand, Victor ULg; Vrolix, M.; De Bruyne, B. et al

in Acta cardiologica (1997), 52(6), 507-14

Detailed reference viewed: 2 (0 ULg)